203 related articles for article (PubMed ID: 24927749)
1. RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.
Surget S; Descamps G; Brosseau C; Normant V; Maïga S; Gomez-Bougie P; Gouy-Colin N; Godon C; Béné MC; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C
BMC Cancer; 2014 Jun; 14():437. PubMed ID: 24927749
[TBL] [Abstract][Full Text] [Related]
2. Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells.
Surget S; Chiron D; Gomez-Bougie P; Descamps G; Ménoret E; Bataille R; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C
Cancer Res; 2012 Sep; 72(17):4562-73. PubMed ID: 22738917
[TBL] [Abstract][Full Text] [Related]
3. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
4. RITA inhibits multiple myeloma cell growth through induction of p53-mediated caspase-dependent apoptosis and synergistically enhances nutlin-induced cytotoxic responses.
Saha MN; Jiang H; Mukai A; Chang H
Mol Cancer Ther; 2010 Nov; 9(11):3041-51. PubMed ID: 21062913
[TBL] [Abstract][Full Text] [Related]
5. p53 regulates CD46 expression and measles virus infection in myeloma cells.
Lok A; Descamps G; Tessoulin B; Chiron D; Eveillard M; Godon C; Le Bris Y; Vabret A; Bellanger C; Maillet L; Barillé-Nion S; Gregoire M; Fonteneau JF; Le Gouill S; Moreau P; Tangy F; Amiot M; Moreau-Aubry A; Pellat-Deceunynck C
Blood Adv; 2018 Dec; 2(23):3492-3505. PubMed ID: 30530776
[TBL] [Abstract][Full Text] [Related]
6. Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma.
Saha MN; Jiang H; Yang Y; Zhu X; Wang X; Schimmer AD; Qiu L; Chang H
PLoS One; 2012; 7(1):e30215. PubMed ID: 22276160
[TBL] [Abstract][Full Text] [Related]
7. A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.
Durand R; Descamps G; Bellanger C; Dousset C; Maïga S; Alberge JB; Derrien J; Cruard J; Minvielle S; Lilli NL; Godon C; Le Bris Y; Tessoulin B; Amiot M; Gomez-Bougie P; Touzeau C; Moreau P; Chiron D; Moreau-Aubry A; Pellat-Deceunynck C
Blood; 2024 Mar; 143(13):1242-1258. PubMed ID: 38096363
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
9. Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other.
Surget S; Lemieux-Blanchard E; Maïga S; Descamps G; Le Gouill S; Moreau P; Amiot M; Pellat-Deceunynck C
Leuk Lymphoma; 2014 Sep; 55(9):2165-73. PubMed ID: 24308434
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces p53-dependent apoptotic signals in myeloma cells with SiRNA-silenced p53: MAP kinase pathway is preferentially activated in cells expressing inactivated p53.
Kircelli F; Akay C; Gazitt Y
Int J Oncol; 2007 Apr; 30(4):993-1001. PubMed ID: 17332940
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
Saha MN; Jiang H; Chang H
Cancer Biol Ther; 2010 Sep; 10(6):567-78. PubMed ID: 20595817
[TBL] [Abstract][Full Text] [Related]
13. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Nardiello T; Jungbluth AA; Mei A; Diliberto M; Huang X; Dabrowski A; Andrade VC; Wasserstrum R; Ely S; Niesvizky R; Pearse R; Coleman M; Jayabalan DS; Bhardwaj N; Old LJ; Chen-Kiang S; Cho HJ
Clin Cancer Res; 2011 Jul; 17(13):4309-19. PubMed ID: 21565982
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
Liu Q; Hilsenbeck S; Gazitt Y
Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793
[TBL] [Abstract][Full Text] [Related]
15. PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance.
Tessoulin B; Descamps G; Moreau P; Maïga S; Lodé L; Godon C; Marionneau-Lambot S; Oullier T; Le Gouill S; Amiot M; Pellat-Deceunynck C
Blood; 2014 Sep; 124(10):1626-36. PubMed ID: 25006124
[TBL] [Abstract][Full Text] [Related]
16. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38.
Weilbacher A; Gutekunst M; Oren M; Aulitzky WE; van der Kuip H
Cell Death Dis; 2014 Jul; 5(7):e1318. PubMed ID: 25010984
[TBL] [Abstract][Full Text] [Related]
17. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM
Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494
[TBL] [Abstract][Full Text] [Related]
18. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.
Misiewicz-Krzeminska I; Sarasquete ME; Quwaider D; Krzeminski P; Ticona FV; Paíno T; Delgado M; Aires A; Ocio EM; García-Sanz R; San Miguel JF; Gutiérrez NC
Haematologica; 2013 Apr; 98(4):640-8. PubMed ID: 23100276
[TBL] [Abstract][Full Text] [Related]
19.
Drozdkova DH; Gursky J; Minarik J; Überall I; Kolar Z; Trtkova KS
Anticancer Res; 2020 Sep; 40(9):4979-4987. PubMed ID: 32878786
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
Endo M; Nishioka T; Numazaki K; Hasegawa H; Takahashi T; Sugawara S; Tada H
Anticancer Res; 2022 Jun; 42(6):2931-2937. PubMed ID: 35641264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
